The early signs of Parkinson’s disease are very often disregarded or mistaken for age, stress, or other disorders ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

Dr. Gina Boerger, PT, DPT, of Fort Loramie, has authored a resource book for people with Parkinson’s disease. Dr. Boerger has ...

Managing patients with Parkinson's disease should be viewed as part of a hospital CMO's responsibility for patient safety and ...

Parkinson’s disease is a challenging condition that affects millions of people around the world. It is known for causing ...

How an AR program may be the key to helping people with Parkinson’s disease manage symptoms. Plus Amazon is partnering with ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

AbbVie ABBV announced positive top-line results from the pivotal phase III TEMPO-2 study, which evaluated its recently ...

Boston-based CervoMed (CRVO) said the Phase 2b trial of its neflamapimod did not meet significant statistical thresholds for its primary endpoint of a change in the Clinical Dementia Rating Sum of ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...